Annual Total Liabilities
$8.89 M
+$1.91 M+27.35%
December 1, 2024
Summary
- As of March 13, 2025, NVCT annual total liabilities is $8.89 million, with the most recent change of +$1.91 million (+27.35%) on December 1, 2024.
- During the last 3 years, NVCT annual total liabilities has fallen by -$8.77 million (-49.65%).
- NVCT annual total liabilities is now -49.65% below its all-time high of $17.66 million, reached on December 31, 2021.
Performance
NVCT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$8.89 M
+$2.58 M+40.82%
December 1, 2024
Summary
- As of March 13, 2025, NVCT quarterly total liabilities is $8.89 million, with the most recent change of +$2.58 million (+40.82%) on December 1, 2024.
- Over the past year, NVCT quarterly total liabilities has increased by +$1.91 million (+27.35%).
- NVCT quarterly total liabilities is now -49.65% below its all-time high of $17.66 million, reached on December 31, 2021.
Performance
NVCT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NVCT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.4% | +27.4% |
| 3 y3 years | -49.6% | +59.5% |
| 5 y5 years | +10000.0% | +59.5% |
NVCT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.6% | +43.8% | -49.6% | +224.8% |
| 5 y | 5-year | -49.6% | >+9999.0% | -49.6% | +224.8% |
| alltime | all time | -49.6% | >+9999.0% | -49.6% | +224.8% |
Nuvectis Pharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $8.89 M(+27.3%) | $8.89 M(+40.8%) |
| Sep 2024 | - | $6.32 M(+9.5%) |
| Jun 2024 | - | $5.77 M(+1.4%) |
| Mar 2024 | - | $5.69 M(-18.5%) |
| Dec 2023 | $6.98 M(+12.9%) | $6.98 M(+25.3%) |
| Sep 2023 | - | $5.58 M(+21.0%) |
| Jun 2023 | - | $4.61 M(+17.2%) |
| Mar 2023 | - | $3.93 M(-36.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $6.19 M(-65.0%) | $6.19 M(+37.7%) |
| Sep 2022 | - | $4.49 M(+64.1%) |
| Jun 2022 | - | $2.74 M(-10.5%) |
| Mar 2022 | - | $3.06 M(-82.7%) |
| Dec 2021 | $17.66 M(>+9900.0%) | $17.66 M(+12.2%) |
| Sep 2021 | - | $15.74 M(+35.5%) |
| Jun 2021 | - | $11.61 M |
| Dec 2020 | $10.00 K | - |
FAQ
- What is Nuvectis Pharma annual total liabilities?
- What is the all time high annual total liabilities for Nuvectis Pharma?
- What is Nuvectis Pharma annual total liabilities year-on-year change?
- What is Nuvectis Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly total liabilities year-on-year change?
What is Nuvectis Pharma annual total liabilities?
The current annual total liabilities of NVCT is $8.89 M
What is the all time high annual total liabilities for Nuvectis Pharma?
Nuvectis Pharma all-time high annual total liabilities is $17.66 M
What is Nuvectis Pharma annual total liabilities year-on-year change?
Over the past year, NVCT annual total liabilities has changed by +$1.91 M (+27.35%)
What is Nuvectis Pharma quarterly total liabilities?
The current quarterly total liabilities of NVCT is $8.89 M
What is the all time high quarterly total liabilities for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly total liabilities is $17.66 M
What is Nuvectis Pharma quarterly total liabilities year-on-year change?
Over the past year, NVCT quarterly total liabilities has changed by +$1.91 M (+27.35%)